$1.61
1.23% day before yesterday
Nasdaq, Jan 02, 10:04 pm CET

Codexis, Inc. Stock price

$1.61
-0.04 2.42% 1M
-1.20 42.70% 6M
-0.02 1.23% YTD
-3.39 67.80% 1Y
-3.05 65.45% 3Y
-19.82 92.49% 5Y
-2.61 61.85% 10Y
-11.65 87.86% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-0.02 1.23%

Key metrics

Basic
Market capitalization
$145.4m
Enterprise Value
$126.5m
Net debt
positive
Cash
$58.7m
Shares outstanding
90.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.7 | 2.1
EV/Sales
2.4 | 1.8
EV/FCF
negative
P/B
3.8
Financial Health
Equity Ratio
44.9%
Return on Equity
-97.5%
ROCE
-56.5%
ROIC
-95.4%
Debt/Equity
1.0
Financials (TTM | estimate)
Revenue
$52.9m | $68.6m
EBITDA
$-54.7m | $-44.9m
EBIT
$-59.6m | $-56.6m
Net Income
$-64.0m | $-60.4m
Free Cash Flow
$-61.7m
Growth (TTM | estimate)
Revenue
-17.9% | 15.6%
EBITDA
-16.2% | 16.1%
EBIT
-17.6% | 3.0%
Net Income
-3.0% | 7.5%
Free Cash Flow
-33.7%
Margin (TTM | estimate)
Gross
79.3%
EBITDA
-103.3% | -65.4%
EBIT
-112.7%
Net
-120.8% | -88.0%
Free Cash Flow
-116.5%
More
EPS
$-0.7
FCF per Share
$-0.7
Short interest
6.6%
Employees
188
Rev per Employee
$320.0k
Show more

Is Codexis, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Codexis, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Codexis, Inc. forecast:

10x Buy
77%
3x Hold
23%

Analyst Opinions

13 Analysts have issued a Codexis, Inc. forecast:

Buy
77%
Hold
23%

Financial data from Codexis, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
53 53
18% 18%
100%
- Direct Costs 11 11
29% 29%
21%
42 42
14% 14%
79%
- Selling and Administrative Expenses 48 48
10% 10%
91%
- Research and Development Expense 48 48
14% 14%
91%
-55 -55
16% 16%
-103%
- Depreciation and Amortization 4.95 4.95
35% 35%
9%
EBIT (Operating Income) EBIT -60 -60
18% 18%
-113%
Net Profit -64 -64
3% 3%
-121%

In millions USD.

Don't miss a Thing! We will send you all news about Codexis, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Codexis, Inc. Stock News

Neutral
GlobeNewsWire
about 2 months ago
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it has signed a lease for a 34,000 square foot GMP manufacturing facility in Hayward, California.
Neutral
Seeking Alpha
about 2 months ago
Codexis, Inc. ( CDXS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Georgia Erbez - CFO & Chief Business Officer Stephen Dilly Alison Moore - President, CEO & Director Britton Jimenez Conference Call Participants Kristen Kluska - Cantor Fitzgerald & Co., Research Division Tollef Kohrman - Craig-Hallum Capital Group LLC, Research Division Chad Wiatrowski - TD Cowen, Re...
Neutral
PRNewsWire
2 months ago
REDWOOD CITY, Calif. , Oct. 29, 2025 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko Avecia, Inc. a leading contract development and manufacturing organization (CDMO) specializing in oligonucleotide therapeutics, today announced that they have entered into an evaluation agreement.
More Codexis, Inc. News

Company Profile

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Head office United States
CEO Stephen Dilly
Employees 188
Founded 2002
Website www.codexis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today